A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Zanidatamab shows promise in extending survival for patients with HER2-positive biliary tract cancer, marking a significant ...
Everyday Health on MSN
The surprising potential of Ozempic and other GLP-1 drugs for type 1 diabetes
GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...
The 2026–2030 Dietary Guidelines for Americans prioritize protein and recommend reducing the intake of added sugars and ultra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback